Related Experiment Video
Updated: Jun 20, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
[Sentinel node biopsy as a prognostic factor in cutaneous melanoma]
J A Avilés-Izquierdo1, P Lázaro-Ochaita
1Servicio de Dermatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain. dermaviles@yahoo.es
Actas Dermo-Sifiliograficas
|August 28, 2009
Summary
Sentinel node biopsy (SNB) in melanoma patients identifies micrometastases, indicating aggressive tumors. While overall survival is unaffected, positive SNB results correlate with lower disease-free survival and increased melanoma mortality.
Area of Science:
- Oncology
- Surgical Pathology
Context:
- Sentinel node biopsy (SNB) is a minimally invasive procedure for staging melanoma.
- Accurate staging is crucial for determining prognosis and guiding treatment in melanoma patients.
Purpose:
- To evaluate the outcomes of SNB in cutaneous melanoma patients.
- To assess the impact of SNB on melanoma patient survival.
Summary:
- SNB identified melanoma micrometastases in 17.6% of 238 patients.
- Tumor thickness and nodular melanoma characteristics were linked to positive SNB results.
- Positive SNB correlated with significantly lower disease-free survival and higher melanoma-related mortality, despite no difference in overall survival.
Impact:
- SNB detection of lymph node micrometastases serves as a key prognostic indicator for tumor aggressiveness.
- SNB findings facilitate improved patient staging and inform subsequent diagnostic and therapeutic strategies.
